Frontlight ResearchEarly access
Trial site
Erlangen
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Childhood cancers2 trials
- Chronic myeloid leukaemia2 trials
- Hidradenitis suppurativa2 trials
- Chronic spontaneous urticaria1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Multiple sclerosis1 trial
- Prostate cancer1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 1/22 trials
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Multiple sclerosis1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026